GLOBOCAN. Cancer Fact Sheets: Breast Cancer Estimated Incidence, Mortality, And Prevalnce Worlwide In 2012. GLOBOCAN (IARC). Available from: globocan.iarc.fr. [11 April 2018].
Kementerian Kesehatan Republik Indonesia. Panduan Penatalaksanaan Kanker Payudara. Komite Penanggulangan Kanker Nasional. Kementrian Kesehatan Indonesia. 2016.
Stewart, B. W. K. P., & Wild, C. P. World cancer report 2014. Health. 2017.
Garland, C. F., Garland, F. C., Gorham, E. D., Lipkin, M., Newmark, H., Mohr, S. B., & Holick, M. F. The role of vitamin D in cancer prevention. American journal of public health, 2006. 96(2), 252-261.
Tokitan, A., Matsumoto, H., Morrison, N., Tawa, T., Miura, Y., Fukamauchi, K., Mitsuhashi, N., Irimoto, M., Yamamori, S., Miura, M., Watanabe, T., Kuwabara, Y., Yabuta, K. and Eisman, J. Vitamin D receptor alleles, bone mineral density and turnover in premenopausal Japanese women. Journal of Bone and Mineral Research, 2009;11(7), pp.1003-1009.
Zhou, H., Xu, C. and Gu, M. Vitamin D receptor (VDR) gene polymorphisms and Graves’ disease: a meta-analysis. Clinical Endocrinology, 2009;70(6), pp.938-945.
Zmuda, J., Cauley, J. and Ferrell, R. Molecular Epidemiology of Vitamin D Receptor Gene Variants. Epidemiologic Reviews, 2000;22(2), pp.203-217.
Lopes, N., Sousa, B., Martins, D., Gomes, M., Vieira, D., Veronese, L., Milanezi, F., Paredes, J., Costa, J. and Schmitt, F. Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions Vitamin D pathways unbalanced in breast lesions. BMC Cancer, 2010;10(1).
Arai, H., Miyamoto, K., Yoshida, M., Yamamoto, H., Taketani, Y., Morita, K., Kubota, M., Yoshida, S., Ikeda, M., Watabe, F., Kanemasa, Y. and Takeda, E. The Polymorphism in the Caudal-Related Homeodomain Protein Cdx-2 Binding Element in the Human Vitamin D Receptor Gene. Journal of Bone and Mineral Research, 2001;16(7), 1256-1264.
Faraco, J., Morrison, N., Baker, A., Shine, J. and Frossard, P. Apa1 dimorphism at the human vitamin D receptor gene locus. Nucleic Acids Research, 17(5), pp.2150-2150.
Gong, Z. The PPAR Pro12Ala polymorphism and risk for incident sporadic colorectal adenomas. Carcinogenesis, 1989;26(3), pp.579-585
Gross, C., Eccleshall, T., Malloy, P., Villa, M., Marcus, R. and Feldman, D. The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal mexican-American women. Journal of Bone and Mineral Research, 2010;11(12), pp.1850-1855.
Ingles, S., Ross, R., Yu, M., Haile, R., Irvine, R., La Pera, G. and Coetzee, G. Association of Prostate Cancer Risk with Genetic Polymorphisms in Vitamin D Receptor and Androgen Receptor. JNCI Journal of the National Cancer Institute, 1997;89(2), pp.166-170.
Morrison, N., Qi, J., Tokita, A., Kelly, P., Crofts, L., Nguyen, T., Sambrook, P. and Eisman, J. Prediction of bone density from vitamin D receptor alleles. Nature, 1994;367(6460), pp.284-287.
Morrison, N., Yeoman, R., Kelly, P. and Eisman, J. Contribution of trans-acting factor alleles to normal physiological variability: vitamin D receptor gene polymorphism and circulating osteocalcin. Proceedings of the National Academy of Sciences, 1992;89(15), pp.6665-6669.
Rashid, M., Muzaffar, M., Khan, F., Kabisch, M., Muhammad, N., Faiz, S., Loya, A. and Hamann, U. Association between the BsmI Polymorphism in the Vitamin D Receptor Gene and Breast Cancer Risk: Results from a Pakistani Case-Control Study. PLOS ONE, 2015;10(10), p.e0141562.
El-Shorbagy HM, Mahmoud NH, Sabet S. Association of vitamin D receptor gene polymorphisms with breast cancer risk in an Egyptian population. Tumor Biology, 2017;1-9.
Guo, B., Jiang, X., Hu, X., Li, F., & Chen, X. Association between vitamin D receptor gene polymorphisms and breast cancer in a Chinese population. International Journal of Clinical and Experimental Medicine, 2015;8(5), 8020–8024.
Dalessandri, K., Miike, R., Wiencke, J., Farren, G., Pugh, T., Manjeshwar, S., DeFreese, D. and Jupe, E. Vitamin D Receptor Polymorphisms and Breast Cancer Risk in a High-Incidence Population: A Pilot Study. Journal of the American College of Surgeons, 2012;215(5), pp.652-657.
Sikandar, B., Qureshi, M. A., Avesi, L., Sheraz, N., & Mirza, T. Histopathological spectrum of breast diseases in a multi-ethnic population of Karachi, Pakistan. Rawal Medical Journal. 2015:40(1), 52-58.
McCullough, M. L., Bostick, R. M., & Mayo, T. L. Vitamin D gene pathway polymorphisms and risk of colorectal, breast, and prostate cancer. Annual review of nutrition. 2009:29, 111-132
Rai, V., Abdo, J. O. E., Agrawal, S., & Agrawal, D. K. Vitamin D receptor polymorphism and cancer: an update. Anticancer research. 2017:37(8), 3991-4003.
Uitterlinden, A. G., Fang, Y., van Meurs, J. B., Pols, H. A., & van Leeuwen, J. P. Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004, 338(2), 143-156.
Raimondi, S., Johansson, H., Maisonneuve, P., & Gandini, S. Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk. Carcinogenesis. 2009:30(7), 1170-1180.
Serrano, D., Gnagnarella, P., Raimondi, S., & Gandini, S. Meta-analysis on vitamin D receptor and cancer risk: focus on the role of TaqI, ApaI, and Cdx2 polymorphisms. European Journal of Cancer Prevention. 2016:25(1), 85.
Lee Y H. Song G G. Vitamin D receptor FokI, BsmI, Apa1, and TaqI polymorphisms and the susceptibility to breast cancer: a meta-analysis. Neoplasma. 2014:61, 5, 2014
Iqbal M N, Khan T A. Association between Vitamin D receptor (Cdx2, Fok1, Bsm1, Apa1, Bgl1, Taq1, and Poly (A)) gene polymorphism and breast cancer: A systematic review and meta-analysis. Tumor Biology. October 2017: 1–9.